Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 8, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

[Total pelvic exenteration].

U Heger1, M Koch, M W Büchler

  • 1Klinik für Allgemein-, Viszeral- und Transplantationschirurgie,Sektion Chirurgische Onkologie, Chirurgische Universitätsklinik, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland.

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|September 14, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemotherapy for patients with circulating tumour DNA-positive, stage II colon cancer (CIRCULATE)-an AIO/ABCSG trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

ESMO gastrointestinal oncology·2026
Same author

Does perioperative hydrocortisone reduce morbidity after pancreatoduodenectomy? A propensity score matched analysis.

Updates in surgery·2025
Same author

A surgical activity model of laparoscopic cholecystectomy for co-operation with collaborative robots.

Surgical endoscopy·2024
Same author

Single chest drain is not inferior to double chest drain after robotic esophagectomy: a propensity score-matched analysis.

Frontiers in surgery·2023
Same author

Ensuring privacy protection in the era of big laparoscopic video data: development and validation of an inside outside discrimination algorithm (IODA).

Surgical endoscopy·2023
Same journal

[S3 Guideline "Adult soft tissue sarcomas"].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Synopsis-S3 guidelines pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Laparoscopic sentinel node navigation surgery in gastric cancer to reduce surgical radicality].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[ASCO guidelines for the treatment of stage III NSCLC part 4: indications for adjuvant therapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Surgical treatment of pancreatic cancer-What is new?]

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
See all related articles

Total pelvic exenteration (TPE) is a safe surgical option for advanced pelvic cancers, offering survival rates up to 66% and good quality of life. TPE is crucial for locally recurrent rectal cancer and can be used palliatively.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastrointestinal Surgery

Background:

  • Total pelvic exenteration (TPE) has become a standard surgical procedure for managing locally advanced pelvic malignancies.
  • Survival rates of up to 66% at 5 years and acceptable quality of life have been documented post-TPE.
  • TPE is increasingly considered even with pelvic side wall infiltration or resectable metastases.

Purpose of the Study:

  • To review the established role and evolving applications of total pelvic exenteration (TPE) in treating advanced pelvic cancers.
  • To highlight the significance of TPE in managing locally recurrent rectal cancer and its palliative potential.
  • To emphasize the necessity of a multidisciplinary approach and specialized centers for TPE procedures.

Main Methods:

Related Experiment Videos

Last Updated: Jun 8, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

  • Review of established surgical techniques and outcomes for total pelvic exenteration (TPE).
  • Analysis of survival data and quality of life reports associated with TPE for various pelvic malignancies.
  • Discussion of indications for TPE, including advanced disease, recurrence, and palliative care.

    • Main Results:

    • TPE is a safe and established technique for locally advanced pelvic malignancies.
    • Five-year survival rates can reach up to 66%, with satisfactory post-surgical quality of life reported.
    • TPE is the primary treatment for resectable locally recurrent rectal cancer and has palliative applications.

    Conclusions:

    • Total pelvic exenteration (TPE) is a viable and effective treatment for advanced pelvic cancers, offering significant survival benefits.
    • The indications for TPE are expanding, encompassing cases with pelvic side wall involvement and resectable metastases.
    • Optimal patient outcomes necessitate a multidisciplinary team and treatment at specialized centers experienced in TPE.